D.E. Shaw & Co
TNXP icon

D.E. Shaw & Co’s Tonix Pharmaceuticals TNXP Stock Holding History

D.E. Shaw & Co’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8
Closed -$1.15M – 5816
2022
Q1 		$1.15M Sell
8
-21
-72% -$3.21M ﹤0.01% 3785
2021
Q4 		$6.68M Buy
29
+19
+190% +$6.04M 0.01% 2072
2021
Q3 		$4.02M Buy
10
+9
+900% +$4.38M 0.01% 2333
2021
Q2 		$834K Buy
+1
New +$735K ﹤0.01% 3690
2016
Q4 		– Hold
0
– -$82K – 3633
2016
Q3 		– Hold
0
– – – 3298
2016
Q2 		– Hold
0
– – – 3046
2016
Q1 		– Hold
0
– – – 3004
2015
Q4 		– Hold
0
– – – 3012
2015
Q3 		– Hold
0
– – – 3370

Other funds holding TNXP

M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return